GeneDx Holdings
46 hedge funds and large institutions have $197M invested in GeneDx Holdings in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.26% more ownership
Funds ownership: 0% → 1.26% (+1.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$27.7M |
| 2 |
LA
Linden Advisors
New York
|
+$22.2M |
| 3 |
Millennium Management
New York
|
+$19.3M |
| 4 |
Blackstone Inc
New York
|
+$16.6M |
| 5 |
TCIM
TOMS Capital Investment Management
New York
|
+$11.2M |
Top Sellers
WGS Hedge Fund Activity: Q4 2020 in Review
46 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q4 2020, worth a combined $197M.
Buyers outnumbered sellers: 46 funds opened new WGS positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Weiss Multi-Strategy Advisers, opening a new position worth an estimated $27.7M.
- 46 institutional investors held GeneDx Holdings (WGS) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $197M of GeneDx Holdings stock for Q4 2020.
- 46 funds opened new GeneDx Holdings positions in Q4 2020 and 0 closed out, a net change of +46 holders.
- The largest GeneDx Holdings buyer in Q4 2020 was Weiss Multi-Strategy Advisers, an estimated $27.7M added.
Based on aggregated 13F filings for Q4 2020.